Fondazione Policlinico Gemelli
Rome, 00168, Italy
NCT Number: NCT05105906
The primary endpoint of the study is the appearance of Post Operative Delirium within the first 3 months.
The secondary endpoints are the development of POCD, dementia of any type of new onset at 12 months, mortality at 30 days, postoperative hospitalization time (including rehabilitation performed within the Polyclinic).. The analysis of the risk factors of POD and their correlation with the development of POCD/Dementia in the post-surgery period will provide important information for the optimization of the management path of these patients at an individual level , with inevitable repercussions on the possibility of reintegration into social and family life
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Rome, 00168, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cognitive tests performed
Time frame: 3 months assessment
Appearance of Post Operative Delirium within the first 3 months after hip surgery
Time frame: 12 months assessment
Development of Post Operative Cognitive Dysfunction, dementia of any type of new onset at 12 months, mortality at 30 days, postoperative hospitalization time
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Post-operative Delirium (POD) Assessment in Patients Undergoing Hip Fracture Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05209555
Cognition Disorders, Cognitive Dysfunction
Eindhoven, Netherlands
View Trial DetailsNCT03293550
Cognition Disorders, Cognitive Dysfunction
Haifa, Israel
View Trial DetailsNCT04289142
Analgesics, Analgesics, Non-Narcotic
Vancouver, British Columbia, Canada
View Trial DetailsNCT05649800
Behavior, Behavioral Symptoms
Leicester, Leicestershire, United Kingdom
View Trial Details